Early behavioural markers of disease in P301S tau transgenic mice

Behavioural Brain Research

Volumn 208, Issue 1, 2010, Pages 250-257

  Scattoni, Maria Luisa ^a   Gasparini, Laura ^b,d   Alleva, Enrico ^a   Goedert, Michel ^c   Calamandrei, Gemma ^a   Spillantini, Maria Grazia ^d  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cognition; FTDP 17; Motor coordination; P301S TAU gene mutation; TAU aggregates; Ultrasonic vocalizations

Indexed keywords

P301S TAU PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG; PROLINE; SERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BEHAVIOR CHANGE; BEHAVIOR DISORDER; C57BL 6 MOUSE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; EXPLORATORY BEHAVIOR; HETEROZYGOTE; HOMOZYGOTE; HYPERACTIVITY; LEARNING; LOCOMOTION; MAZE TEST; MENTAL TASK; MOTOR COORDINATION; MOTOR PERFORMANCE; NONHUMAN; OLFACTORY STIMULUS; OPEN FIELD TEST; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SENSORY STIMULATION; SPATIAL LEARNING; SPONTANEOUS BEHAVIOR; TAUOPATHY; TRANSGENIC MOUSE; ULTRASOUND; VOCALIZATION; AGE; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; ASSOCIATION; BODY WEIGHT; BRAIN; C57BL MOUSE; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; MOUSE; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; ROTAROD TEST; SPINAL CORD; VISION;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; CUES; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; HUMANS; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; PROLINE; ROTAROD PERFORMANCE TEST; SERINE; SPINAL CORD; TAU PROTEINS; TAUOPATHIES; VISUAL PERCEPTION; VOCALIZATION, ANIMAL;

EID: 77951927095     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.12.002     Document Type: Article

References (39)

1. Allen B., Ingram E., Takao M., Smith M.J., Jakes R., Virdee K., et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 2002, 22:9340-9351.
2. Arendash G.W., Lewis J., Leighty R.E., McGowan E., Cracchiolo J.R., Hutton M., et al. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Res 2004, 1012:29-41.
3. Balsis S., Carpenter B.D., Storandt M. Personality change precedes clinical diagnosis of dementia of the Alzheimer type. J Gerontol B Psychol Sci Soc Sci 2005, 60:P98-P101.
4. Blumberg M.S., Alberts J.R. Ultrasonic vocalizations by rat pups in the cold: an acoustic by-product of laryngeal braking?. Behav Neurosci 1990, 104:808-817.
5. Boekhoorn K., Terwel D., Biemans B., Borghgraef P., Wiegert O., Ramakers G.J., et al. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. J Neurosci 2006, 26:3514-3523.
6. Branchi I., Ricceri L. Transgenic and knock-out mouse pups: the growing need for behavioral analysis. Genes Brain Behav 2002, 1:135-141.
7. Crawley J.N. What's wrong with my mouse? Behavioral phenotyping of transgenic and knockout mice 2007, Wiley-Interscience, Hoboken, NJ.
8. Delobel P., Lavenir I., Fraser G., Ingram E., Holzer M., Ghetti B., et al. Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy. Am J Pathol 2008, 172:123-131.
9. Ehret G. Infant rodent ultrasounds-a gate to the understanding of sound communication. Behav Genet 2005, 35:19-29.
10. Gallagher M., Burwell R., Burchinal M. Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze. Behav Neurosci 1993, 107:618-626.
11. Gasparini L., Terni B., Spillantini M.G. Frontotemporal dementia with tau pathology. Neurodegener Dis 2007, 4:236-253.
12. Hickey M.A., Gallant K., Gross G.G., Levine M.S., Chesselet M.F. Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing. Neurobiol Dis 2005, 20:1-11.
13. Hofer M.A., Shair H.N., Brunelli SA Ultrasonic vocalizations in rat and mouse pups. Curr Protoc Neurosci 2002, Chapter 8: Unit 8 14.
14. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
15. Ikeda M., Shoji M., Kawarai T., Kawarabayashi T., Matsubara E., Murakami T., et al. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice. Am J Pathol 2005, 166:521-531.
16. Ittner L.M., Fath T., Ke Y.D., Bi M., van Eersel J., Li K.M., et al. Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proc Natl Acad Sci USA 2008, 105:15997-16002.
17. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 2000, 25:402-405.
18. Littin K., Acevedo A., Browne W., Edgar J., Mendl M., Owen D., et al. Towards humane end points: behavioural changes precede clinical signs of disease in a Huntington's disease model. Proc Biol Sci 2008, 275:1865-1874.
19. Magnani E., Fan J., Gasparini L., Golding M., Williams M., Schiavo G., et al. Interaction of tau protein with the dynactin complex. Embo J 2007, 26:4546-4554.
20. Manciocco A., Chiarotti F., Vitale A., Calamandrei G., Laviola G., Alleva E. The application of Russell and Burch 3R principle in rodent models of neurodegenerative disease: the case of Parkinson's disease. Neurosci Biobehav Rev 2009, 33:18-32.
21. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984, 11:47-60.
22. Paulsen J.S., Langbehn D.R., Stout J.C., Aylward E., Ross C.A., Nance M., et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 2008, 79:874-880.
23. Pennanen L., Welzl H., D'Adamo P., Nitsch R.M., Gotz J. Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice. Neurobiol Dis 2004, 15:500-509.
24. Pennanen L., Wolfer D.P., Nitsch R.M., Gotz J. Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice. Genes Brain Behav 2006, 5:369-379.
25. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998, 43:815-825.
26. Ramsden M., Kotilinek L., Forster C., Paulson J., McGowan E., SantaCruz K., et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci 2005, 25:10637-10647.
27. Schindowski K., Bretteville A., Leroy K., Begard S., Brion J.P., Hamdane M., et al. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 2006, 169:599-616.
28. Simuni T., Sethi K. Nonmotor manifestations of Parkinson's disease. Ann Neurol 2008, 64(Suppl. 2):S65-S80.
29. Spillantini M.G., Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci 1998, 21:428-433.
30. Spillantini M.G., Murrell J.R., Goedert M., Farlow M.R., Klug A., Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998, 95:7737-7741.
31. Spittaels K., Van den Haute C., Van Dorpe J., Geerts H., Mercken M., Bruynseels K., et al. Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem 2000, 275:41340-41349.
32. Stepaniuk J., Ritchie L.J., Tuokko H. Neuropsychiatric impairments as predictors of mild cognitive impairment, dementia, and Alzheimer's disease. Am J Alzheimers Dis Other Demen 2008, 23:326-333.
33. Talassi E., Cipriani G., Bianchetti A., Trabucchi M. Personality changes in Alzheimer's disease. Aging Ment Health 2007, 11:526-531.
34. Tanemura K., Akagi T., Murayama M., Kikuchi N., Murayama O., Hashikawa T., et al. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau. Neurobiol Dis 2001, 8:1036-1045.
35. Tanemura K., Murayama M., Akagi T., Hashikawa T., Tominaga T., Ichikawa M., et al. Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J Neurosci 2002, 22:133-141.
36. Tatebayashi Y., Miyasaka T., Chui D.H., Akagi T., Mishima K., Iwasaki K., et al. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc Natl Acad Sci USA 2002, 99:13896-13901.
37. Terwel D., Lasrado R., Snauwaert J., Vandeweert E., Van Haesendonck C., Borghgraef P., et al. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J Biol Chem 2005, 280:3963-3973.
38. Wolfer D.P., Lipp H.P. Dissecting the behaviour of transgenic mice: is it the mutation, the genetic background, or the environment?. Exp Physiol 2000, 85:627-634.
39. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 53:337-351.